Literature DB >> 8682173

Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology.

W R Galpern1, L H Burns, T W Deacon, J Dinsmore, O Isacson.   

Abstract

Neurotransplantation of human fetal dopamine (DA) neurons is currently being investigated as a therapeutic modality for Parkinson's disease (PD). However, the practical limitations of human fetal transplantation indicate a need for alternative methodologies. Using the 6-hydroxydopamine rat model of PD, we transplanted dopaminergic neurons derived from Embryonic Day 27 porcine fetuses into the denervated striatum of cyclosporine-A (CyA)-treated or non-CyA-treated rats. Functional recovery was assessed by amphetamine-induced rotation, and graft survival and morphology were analyzed using neuronal and glial immunostaining as well as in situ hybridization with a porcine repeat element DNA probe. A significant, sustained reduction in amphetamine-induced rotational asymmetry was present in the CyA-treated rats whereas the non-CyA-treated rats showed a transient behavioral recovery. The degree of rotational recovery was highly correlated to the number of surviving transplanted porcine dopaminergic neurons. TH+ neuronal survival and graft volume were significantly greater in the CyA-treated group as compared to the non-CyA group. By donor-specific neuronal and glial immunostaining as well as donor-specific DNA labeling, we demonstrate that porcine fetal neuroblasts are able to survive in the adult brain of immunosuppressed rats, mediate functional recovery, and extensively reinnervate the host striatum. These findings suggest that porcine DA neurons may be a suitable alternative to the use of human fetal tissue in neurotransplantation for PD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682173     DOI: 10.1006/exnr.1996.0109

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  25 in total

Review 1.  Immune problems in central nervous system cell therapy.

Authors:  Roger A Barker; Håkan Widner
Journal:  NeuroRx       Date:  2004-10

2.  Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation.

Authors:  Caroline Martin; Martine Plat; Véronique Nerriére-Daguin; Flora Coulon; Svetlana Uzbekova; Eric Venturi; Françoise Condé; Jean-Michel Hermel; Philippe Hantraye; Laurent Tesson; Ignacio Anegon; Benoit Melchior; Marc Peschanski; Brigitte Le Mauff; Françoise Boeffard; Solène Sergent-Tanguy; Isabelle Neveu; Philippe Naveilhan; Jean-Paul Soulillou; Michel Terqui; Philippe Brachet; Bernard Vanhove
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

3.  Development of histocompatible primate-induced pluripotent stem cells for neural transplantation.

Authors:  Michela Deleidi; Gunnar Hargus; Penelope Hallett; Teresia Osborn; Ole Isacson
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

Review 4.  Innovative strategies in the management of acute stroke.

Authors:  Lawrence R Wechsler
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

5.  Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft.

Authors:  Daniela Ferrari; Rosario Sanchez-Pernaute; Hyojin Lee; Lorenz Studer; Ole Isacson
Journal:  Eur J Neurosci       Date:  2006-10       Impact factor: 3.386

Review 6.  Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells.

Authors:  Paolina Pantcheva; Stephanny Reyes; Jaclyn Hoover; Sussannah Kaelber; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2015-09-22       Impact factor: 4.618

7.  Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats.

Authors:  Dali Yang; Zhi-Jian Zhang; Michael Oldenburg; Melvin Ayala; Su-Chun Zhang
Journal:  Stem Cells       Date:  2007-10-18       Impact factor: 6.277

8.  Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease.

Authors:  Richard J E Armstrong; Pamela Tyers; Meena Jain; Andrew Richards; Stephen B Dunnett; Anne E Rosser; Roger A Barker
Journal:  Exp Brain Res       Date:  2003-06-03       Impact factor: 1.972

9.  Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.

Authors:  D E Redmond; A Vinuela; J H Kordower; O Isacson
Journal:  Neurobiol Dis       Date:  2007-08-28       Impact factor: 5.996

10.  Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Authors:  A Vinuela; P J Hallett; C Reske-Nielsen; M Patterson; T D Sotnikova; M G Caron; R R Gainetdinov; O Isacson
Journal:  Brain       Date:  2008-11-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.